XADAGO 50 MG TABLET

safinamide mesylate
$36.4150per EA

Strength

50 mg/1

NDC

27505011030

Classification

Brand

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

1/21/2026

Active Ingredients

SAFINAMIDE MESYLATE

Approval Type

New Drug (NDA)

FDA Application

NDA207145

On Market Since

5/8/2017

Pharmacological Classes

Breast Cancer Resistance Protein Inhibitors
Monoamine Oxidase Type B Inhibitor
Monoamine Oxidase-B Inhibitors

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

-0.1%

1Y

-0.3%

3Y

N/A

5Y

N/A

All

-0.4%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.